Literature DB >> 29217949

The Effect of Psychosocial Factors and Patients' Perception of Tuberculosis Treatment Non-Adherence in Addis Ababa, Ethiopia.

Habteyes Hailu Tola1,2, Gholamreza Garmaroudi1, Davoud Shojaeizadeh1, Azar Tol1, Mir Saeed Yekaninejad3, Luche Tadesse Ejeta1, Abebaw Kebede2, Desta Kassa2.   

Abstract

BACKGROUND: Although there are several studies reported on factors affecting tuberculosis (TB) treatment non-adherence, there is information gap on psychosocial and patients' perceptions aspects. Therefore, this study was aimed to investigate the effect of psychosocial factors and patients' perceptions on TB treatment non-adherence in Ethiopia.
METHODS: A cross sectional study was conducted in Addis Ababa from May to December, 2014. Thirty one health facilities were randomly selected and 698 TB patients, who had been on treatment, were enrolled consecutively using patient registration number. Structured questionnaire was used to collect data on demographics, knowledge, psychological distress, alcohol use, tobacco smoking and six HBM domains. Treatment adherence level was the main outcome variable, and it measured using visual analog scale. Statistical Package for Social Sciences version 20 was used for data analysis.
RESULTS: Non-adherence level within last one month prior to the study was 19.5%. After controlling for all potential confounding variables, Antiretroviral Therapy (ART) status (Adjusted Odds Ratio (AOR) = 1.79, 95% Confidence interval (CI) (1.09 -2.95)), alcohol use (AOR = 2.11, 95% CI (1.33-3.37)), economic status (AOR = 0.53, 95% CI (0.33-0.82)), perceived barriers (AOR = 1.21, 95% CI (1.10-1.47)) and psychological distress (AOR = 1.83, 95% CI (1.47-2.29)) were independently associated with TB treatment non-adherence.
CONCLUSION: ART status, economic status, alcohol use, perceived barrier and psychological distress are the major areas that need to be targeted with health promotion intervention to enhance TB treatment adherence.

Entities:  

Keywords:  Determinants of treatment non-adherence; Health Belief Model; Treatment Non-adherence; Tuberculosis

Mesh:

Substances:

Year:  2017        PMID: 29217949      PMCID: PMC5615005          DOI: 10.4314/ejhs.v27i5.2

Source DB:  PubMed          Journal:  Ethiop J Health Sci        ISSN: 1029-1857


Introduction

Non-adherence to long term treatment is one of the major problems, which leads to poor treatment outcome due to its high risk of treatment failure and long term disease transmission (1,2). For instance, if we take the effect of drug resistance, the emergence of drug-resistance microbes is posing challenges to prevention and control programs of Tuberculosis (TB) (2–4). TB treatment non-adherence can also results in the occurrence of Multidrug Resistance, Extensively Drug Resistant TB (MDR-TB and XDR-TB) bacilli (3). According to WHO report, 3.6% and 20.2% of MDR-TB cases were registered among new and previously treated cases respectively in 2013 (5). Apart from treatment failure and the occurrence of MDR-TB, treatment non-adherence has several socioeconomic impacts (6–8). For example, it can increase duration of treatment (6) and hospital bed occupancy rate (6–8), economic depletion and dependency (8), and induction of mental illness (7). Treatment adherence is a complex phenomenon that is influenced by a wide range of interacting factors (7,9). Depression and anxiety, individual negative emotional status (10,11) and fear of stigma (12), general disease and its treatment knowledge (12–17), patients' perception of the disease and its treatment (18–20), lack of social support, and economic hardships are associated with TB treatment non-adherence (12,15–17,21). Moreover, poorly oriented health services, poor medication distribution, poor communication and others are factors related to health care workers and the health system itself in respect to TB treatment adherence (16,17,22,23). On the other hand, studies show that alcohol consumption and tobacco smoking history (16,17,24–26) and patients' HIV and Antiretroviral (ART) status are associated with TB treatment non-adherence (21,27). Although previous studies reported several determinants of TB treatment non-adherence, few of them assessed the effect of psychosocial factors and individual patient's perception on TB treatment non-adherence. Moreover, though it is recommended to use social and behavioural science theoretical models to generate strong evidence on health promotion including treatment adherence (9,28,29) few studies have so far applied theoretical models to assess determinant factors of TB treatment non-adherence. In Ethiopia, few studies have been conducted to assess determinant factors of TB treatment non-adherence, and based on these studies, the proportion of non-adherence rages from 10% to 21% (13,14,27). Apart from scarcity of information in Ethiopia, there is no study conducted based on theoretical models to determine psychosocial factors and individual patient's perception that influence TB treatment non-adherence. In addition, although previous studies conducted in Ethiopia reported numerous determinants of TB treatment non-adherence, none of them reported the effect of psychosocial factors and individual patient's perception based on theoretical model (13,14,22,27). Therefore, this study was aimed to determine the effect of psychosocial and individual patient's perception on TB treatment non-adherence based on Health Belief Model (HBM) in Ethiopian. HBM is the most widely used and important model to understand and explain health behaviors including treatment adherence as a healthy practice (30,31). However, it is being criticized for focusing on individual characteristics and cognitive factors, giving less attention to social influences and emotional components of behavior. This theoretical model consists of six domains in its recent version (29). These are perceived susceptibility, perceived severity, perceived benefits, perceived barriers, cue to action and perceived self-efficacy (29). According to HBM concept, TB patients with a given sociodemographic characteristics and mental health status are likely to follow their medicinal regimen correctly under a specific five sets of conditions (31,32). These are: TB patients must have some minimal knowledge on their illness and motivation to be free of TB; TB patients must perceive themselves as susceptible to TB and must also believe that TB disease and consequences of non-adherence can cause serious medical and health problems; TB patients must also be influenced by the effectiveness of TB treatment, which could result in the possibility to obtain control over the tangible and psychological barriers at acceptable level; The presence of an internal or external stimulus, referred as “cue to action,” is a trigger of adherence behavior of TB patients'; and TB patients' trust in self-ability to strictly follow the treatment till the final dose. Based on the HBM theoretical concepts mentioned above, this study applied the model to determine the effect of psychosocial factors and individual patient's perception on TB treatment adherence.

Methods

Study design and setting: A cross sectional study was conducted to determine the effect of psychosocial factors and individual patient's perception on TB treatment non-adherence in Addis Ababa from May to December, 2014. Addis Ababa consists of 10 sub-cities with an estimated total population 2,975,608 (33). In addition, it consists of 53 health centers and 10 public hospitals (34). All diagnosed TB patients are treated under Directly Observed Treatment (DOT) strategy (35). Study population and sampling: The study population was all types of TB patients who were on first line and MDR-TB treatment regimens under Directly Observed Treatment Short course (DOTS) strategy in randomly selected 30 Health Centers (HCs) and one purposively selected TB specialized hospital in Addis Ababa. Thirty HCs were selected using simple random sampling technique from 53 HCs, located in the city. The number of HCs (clusters) selected was set at 30 based on WHO recommendation regarding minimum number of survey clusters (36). From selected study sites, 698 TB patients, who had been on treatment for one month and above, older than 17 years and living in Addis Ababa for more than six months were enrolled consecutively from TB registration book using patients' identification numbers. However, severely sick and mentally incapable patients were excluded. Consecutive enrollment of participants from registration book was used to achieve the maximum sample size and to avoid selection bias. Data collection instrument and procedure: A structured questionnaire was used to collect sociodemographic data. Economic status was assessed with 10 structured questions which ask ownership position of basic assets. The response of each question was recorded by yes = 1 and no = 0. To estimate the total score of economic status, one dimension Categorical Principal Component Analysis (CPCA) technique was used. Thirty eight structured items were employed to collect TB disease and its treatment related knowledge. The responses to each knowledge question were recorded on three level Likert's scale such as “correct”, “incorrect” and “don't know”. One point was given for each correct answer (correct response score = 1) and zero for incorrect and don't know responses (incorrect and don't know responses score = 0) (Table 1). The total knowledge score was calculated using total sum method. In addition, a total of 76 structured items were designed based on literature review and the concept of HMB to collect information on six HBM domains. The degree with which each of these items expressed was recorded using a five-point Likert's scale ranging from “strongly disagree” with lower score (1) to “strongly agree” with higher score (5) (Table 1). Total perception score of each HBM domain was estimated by CPCA. To show frequency distribution of non-adherence level with respect to knowledge and perception levels, total knowledge score and total HBM domains scores were dichotomized using median score of each variable as a cut-off point. However, in the logistic regression modeling, continuous scores of knowledge and HBM domains were used (Table 4). To assess the presence of psychological distress symptoms characterized by depression and anxiety in the last one month, Kessler-10 items (K-10) scale was used (37,38). The frequency with which each of these items experienced was recorded using a five-point Likert's scale ranging from “none of the time” with lower score to “all the time” with higher score (Table 1). The total psychological distress score was estimated by CPCA. This scale has been largely used to assess common mental disorders (CMDs) among TB patients, and has been validated in several settings (39) including in Ethiopia (40). WHO Alcohol Use Disorder Identification Test (AUDIT) 10 items was used to assess alcohol use history (41), while tobacco smoking history was collected using Australian Smoking Assessment Check list (42). Information on TB patients' HIV and ART status was collected from participant self-report and rechecked from TB registration book. The questionnaire was validated prior to use for main study data collection by test and retest pilot study at selected study sites. Internal consistency of HBM domains and other variables were assessed using Cronbach's α analysis and the results were in acceptable range (0.70) (Table 1). Adherence level of patients was assessed by participant self report with Visual Analogues Scale (VAS) after carful explanation. In addition, participants who interrupted treatment due to medication adverse effect and lost to follow-up were interviewed through home visit after agreement was obtained through telephone call. VAS was scaled from 0% to 100% and re-coded to dichotomous variable (adherent or non-adherent) using 90% cut-off point based on WHO adherence definition (4). WHO defines TB treatment non-adherent as “patients who did not attend a health facility at the scheduled visit and those who did not take regular medication above 90% of prescribed doses” (4). Therefore, in this study, non-adherent patients were: (1) those who scored their adherence level less than 90%, (2) those who interrupted their treatment due to medication adverse effects, and (3) those who were lost to follow-up.
Table 1

Response score mean standard deviation and Cronbach's alpha of knowledge, psychological distress and each HBM domain

VariableNo. ItemsScaleMean scoreStandard deviationCronbach's alpha
Knowledge Score380–130.54.70.85
Perceived Susceptibility91–528.26.60.78
Perceived Severity91–536.95.00.76
Perceived Benefit81–532.84.10.80
Perceived Barrier311–565.516.60.75
Cue to action71–531.75.30.77
Perceived Self-efficacy121–551.55.60.82
Psychological distress101–518.717.830.93
Alcohol use disorder100–43.52.70.90
Table 4

Predictors of TB treatment non-adherence

CharacteristicsCrud OR (95% CI)P-ValueAdjusted OR (95% CI)P-Value
GenderFemale1.00
Male0.83(0.57–1.21)0.335
Marital StatusMarried1.000.476
Unmarried1.17(0.78–1.76)
Diploma &1.00
Educational StatusAbove
High School & Less2.17(1.06–4.46)0.0532.1(0.99–4.52)0.053
Current Smoking HistoryNon-smoking1.00
Smoker1.29(0.69–2.42)0.495
TB Treatment HistoryNew1.00
Previously1.50(1.00–2.27)0.0591.43(0.90–2.25)0.128
Treated
TB TypeEPTB1.00
PTB1.43(0.93–2.18)0.267
HIV Sero-statusNone1.00
Reactive
Reactive0.86(0.55–1.35)0.561
ART* StatusNot on ART1.00
On ART1.73(1.09–2.73)0.0221.79(1.09–2.95)0.023
AUDRNo Risk1.00
There is Risk2.06(1.29–3.29)0.0012.11(1.33–3.37)0.002
Age (in year)1.00(0.99–1.02)0.843
Economic Status0.52(0.35–0.76)0.0010.53(0.33–0. 82)0.004
Psychological Distress1.65(1.45–2.00)<0.0011.83(1.47–2.29)<0.001
Knowledge0.99(0.96–1.03)0.7630.98(0.96–1.05)0.841
Perceived Susceptibility0.81(0.67–1.00)0.0510.81(0.62–1.05)0.106
Perceived Severity0.80(0.68–0.95)0.0780.95(0.73–1.23)0.678
Perceived Barrier1. 35(1.16–1.57)<0.0011.21(1.10–1.47)0.014
Perceived Benefit0.81(0.78–1.21)0.0590.89(0.69–1.15)0.243
Cue to Action0.82(0.70–0.97)0.0190.85(0.67– 1.10)0.203
Perceived Self-efficacy0.88(0.78–0.99)0.0340.98(0.77–1.17)0.224

ART-Antiretroviral Therapy,

PTB-Pulmonary TB,

EPTB-Extra Pulmonary TB,

AUD-Alcohol Use

Response score mean standard deviation and Cronbach's alpha of knowledge, psychological distress and each HBM domain Predictors of TB treatment non-adherence ART-Antiretroviral Therapy, PTB-Pulmonary TB, EPTB-Extra Pulmonary TB, AUD-Alcohol Use Data was collected by health professionals at each study site. Before data collection, a three days' training was offered to data collectors on how to administer the questionnaire. Data collectors were supervised during data collection on regular basis. Data entry and analysis: Data was analyzed using Statistical Package for Social Science (SPSS) version 20. Proportions of non-adherence among participants' characteristics, knowledge score, six HBM domains scores and psychological distress score were determined to show the frequency distribution of treatment non-adherence. Before running multivariable logistic regression, bivariate analysis was conducted between each independent variable and non-adherence level. Variables with p-value less than 0.2 in bivariate analysis were included in multiple logistic regressions. However, although knowledge and the six HMB domains had p-value greater than 0.2, they were included in the final model because they were the main exposure variables in the study and the main constructs of HBM model. Ethical approval: This study protocol was ethically approved by Tehran University of Medical Sciences and the Ethiopian Public Health Institute Research Ethics Board. Both oral and written informed consent was obtained from each study participant.

Results

Sociodemographic characteristics: A total of 698 all forms of TB [Pulmonary = 416(59.6%)), Extra pulmonary = 215(30.8%), MDR-TB = 67(9.6%)] patients on treatment for one and above months were included in the study (Table 2). The age range of participants was 18–90 years, and about 457(65.5%) participants were less than 35 years of age. More than half (55.9%) of the participants were elementary school and below in terms of educational attainment, and 53.4% were unemployed and daily laborers (Table 2). About 29.3% participants were migrants from rural areas to Addis Ababa and of these, 18.1% were daily laborers.
Table 2

Study Participants' Characteristics (n = 698)

VariablesFrequency95% CI of %
GenderFemale29742.6(38.9 – 46.3)
Male40157.4(53.8 – 61.1)
18–2419327.7(24.5 – 31.1)
Age Groups (in year)25–3426437.8(34.3 – 41.5)
35–4413619.5(16.7 – 22.6)
45 & above10414.9(12.4 – 17.7)
Missing10.1(0.0 – 0.9)
Elementary & less39055.9(52.2 – 59.5)
Educational StatusHigh School Graduate22432.1(28.3 – 35.6)
Diploma & Above8412.0(9.8 – 14.7)
Marital StatusMarried22432.1(28.7 – 35.6)
Unmarried47467.9(64.4 – 71.3)
Employed32546.6(42.9 – 50.3)
Employment StatusUnemployed29442.1(38.5 – 45.8)
Daily Laborer7911.3(9.2 – 13.9)
Current Smoking HistorySmoker608.6(6.7 – 10.9)
None Smoker63891.4(89.1 – 93.3)
TB Treatment HistoryNew52775.5(72.2 – 78.5)
Previously Treated17124.5(21.5 – 27.8)
PTB41659.6(55.9 – 63.2)
TB typeEPTB21530.8(27.5 – 34.3)
MDR-TB§679.6(7.6 – 12.0)
HIV Sero-statusNone Reactive54878.5(75.3 – 81.4)
Reactive15021.5(18.6 – 24.7)
ART* StatusNot on ART58183.2(80.3 – 85.8)
On ART11716.8(14.2 – 19.7)
Alcohol Use Disorder RiskThere is Risk10515.0(12.6 – 17.9)
No Risk59385.0(82.1 – 87.4)
Psychological Distress SymptomNo Symptom35751.1(47.4 – 54.8)
There is Symptom34148.9(45.2 – 52.6)

ART-Antiretroviral Therapy,

PTB-Pulmonary TB,

EPTB-Extra Pulmonary TB,

MDR-TB-Multidrug Resistant TB

Study Participants' Characteristics (n = 698) ART-Antiretroviral Therapy, PTB-Pulmonary TB, EPTB-Extra Pulmonary TB, MDR-TB-Multidrug Resistant TB Table 3 depicts proportions of non-adherence with respect to study participants' characteristics. A total of 136(19.5%) participants were non-adherent. Of the total non-adherent participants, males were slightly more, 73(53.7), than females 63(46.3%). Participants in the age group of less than 35 years were more non-adherent, 91(66.9%), compared to other age groups. Similarly, large proportions of non-adherent participants were unmarried (70.6%), elementary school and below, (60.3%), at low socioeconomic status, (61.8%), newly started TB treatment, (70%), and pulmonary TB patients, (64.7%).
Table 3

Participant characteristics distribution of TB treatment non-adherence

CharacteristicsAdherence

Adherent% (95% CI)Non-Adherent% (95% CI)
GenderFemale23441.6(37.6 – 45.8)6346.3(38.2 – 54.7)
Male32858.4(54.2 – 62.4)7353.7(45.3 – 61.8)
18–2416028.5(24.9 – 32.3)3324.3(17.8 – 32.2)
Age Group25–3420636.7(32.8 – 40.7)5842.6(34.7 – 51.1)
35–4411119.8(16.7 – 23.3)2518.4(12.7 – 25.8)
45 & Above8414.9(12.2 – 18.1)2014.7(9.7 – 21.7)
Marital StatusMarried18432.7(29.0 – 36.7)4029.4(22.4 – 37.6)
Unmarried37867.3(63.3 – 71.0)9670.6(62.4 – 77.6)
Employed27148.2(44.1 – 52.4)5439.7(31.9 – 48.1)
EmploymentUnemployed22940.7(36.8 – 44.9)6547.8(39.6 – 56.1)
StatusDaily Laborer6211.0(8.7 – 13.9)1712.5(7.9 – 19.2)
Elementary & less30854.8(50.7 – 58.9)8260.3(51.9 – 68.1)
EducationalHigh School17931.9(28.1 – 35.8)4533.1(25.7 – 41.4)
StatusDiploma & above7513.3(10.8 – 16.4)96.6(3.4 – 12.3)
Economic StatusLow23341.5(37.5 – 45.6)8461.8(53.4 – 69.5)
Medium14626.0(22.5 – 29.8)3425.0(18.5 – 32.9)
High18332.6(28.8 – 36.6)1813.2(8.5 – 20.0)
Current SmokingSmoker468.2(6.2 – 10.8)1410.3(6.1 – 16.7)
HistoryNone Smoker51691.8(89.2 – 93.8)12289.7(83.4 – 93.9)
TB TreatmentNew43377.0(73.4 – 80.3)9469.1(60.9 – 76.3)
HistoryPreviously Treated12923.0(19.7 – 26.6)4230.9(23.7 – 39.1)
PTB32858.4(54.2 – 62.4)8864.7(56.4 – 72.2)
TB typeEPTB18132.2(28.3 – 36.2)3425.0(18.5 – 32.9)
MDR-TB§539.4(7.3 – 12.2)1410.3(6.1 – 16.6)
HIV Sero StatusNone Reactive44479.0(75.4 – 82.2)10476.5(68.6 – 82.9)
Reactive11821.0(17.8 – 24.6)3223.5(17.2 – 31.4)
ART Status*On ART8014.2(11.6 – 17.4)3223.5(17.2 – 31.4)
Not on ART47784.9(81.7 – 87.6)10476.5(68.4 – 82.9)
AUDNo Risk48987.0(84.0 – 89.6)10476.5(68.4 – 82.9)
There is Risk7313.0(10.5 – 16.0)3223.5(17.2 – 31.4)
PDS**No Symptom29352.1(48.0 – 56.2)6447.1(38.9 – 55.4)
There is Symptom26947.9(43.8 – 52.0)7252.9(44.6 – 61.1)

ART-Antiretroviral Therapy,

PTB-Pulmonary TB,

EPTB-Extra Pulmonary TB,

MDR-TB-Multidrug Resistant TB,

AUD-Alcohol Use Disorder,

PDS-Psychological distress symptom

Participant characteristics distribution of TB treatment non-adherence ART-Antiretroviral Therapy, PTB-Pulmonary TB, EPTB-Extra Pulmonary TB, MDR-TB-Multidrug Resistant TB, AUD-Alcohol Use Disorder, PDS-Psychological distress symptom Knowledge and perception regarding TB disease and its treatment: The mean knowledge score of the participants was 30.5 (±4.7), and 59.0% of them were scored more than mean score of knowledge. Among non-adherent participants, 92(67.7%) scored less than the mean knowledge score. The mean perceived susceptibility and perceived severity scores were 28.2 (SD = 6.6) and 36.9 (SD = 5.0) respectively. Similarly, the mean score of perceived barrier was 65.5 (SD = 16.6) and the mean score of perceived benefit was 32.8(SD = 4.1). Moreover, the mean score of cue to action and perceived self-efficacy were 31.7(SD = 5.3) and 51.5 (SD = 5.6) respectively (Table 3). Alcohol use and tobacco smoking: The mean alcohol use disorder score on WHO 10 items AUDIT was 3.5(SD = 2.7). Using WHO AUDIT cut-off point (greater than 8 total score) 111(15.0%) of the participants fulfilled hazardous and harmful alcohol use as well as possible alcohol dependence. Out of the total non-adherence, (19.5%), 42(28%) of the participants had alcohol use disorder symptoms. More than 90% of the participants were non-smoker, and of the total (60) smokers, 14(23.3%) participants were non-adherent, while slightly lower (19.1%) were non-adherent from non-smokers. Psychological distress: The mean score of psychological distress was 18.7(SD = 7.8) on K- 10 items. Slightly less than half (48.9%) of the participant met the criteria for psychological distress on cut-off point of 15 score. Of 136(19.5%) the total non-adherence, 76(27.4%) showed symptoms of psychological distress. Bivariate analysis: On Bivariate analysis (Table 4), high school completion (Crude Odds Ratio (COR) = 2.17, 95% Confidence Interval (CI), (1.06–4.46)), being on ART (COR = 1.73, 95% CI (1.09–2.73)), availability of AUD (COR = 2.06, 95% CI (1.29–3.29)), high economic status (COR = 0.52, 95% CI (0.35–0.76)), perceived barriers (COR = 1.35, 95% CI (1.35–1.16)) and psychological distress (COR = 1.65, 95% CI (1.45–2.00) were significantly associated with TB treatment non-adherence. Multivariate analysis: The final multivariable logistic regression model contains five independent variables (ART status, TB treatment history, educational status, economic status, knowledge level), and six HBM domains indicated a high goodness of fit with the data (χ2 =70.07, p<0.001), demonstrating that the model was able to differentiate between participants who were adherent and non-adherent. The final multivariable logistic regression analysis revealed that, being on ART (Adjusted Odds Ratio (AOR) = 1.79, 95% CI (1.09–2.95)), AUD (AOR = 2.11, 95% CI (1.33–3.37)), high economic status (AOR = 0.53, 95% CI (0.33–0. 82)), perceived barrier (AOR = 1.21, 95% CI (1.10–1.47)) and psychological distress (AOR = 1.83, 95% CI (1.47–2.29)) were independently associated with treatment non-adherence (Table 4).

Discussion

For successful treatment outcome, optimal treatment adherence is mandatory. According to WHO, to be adherent, patient should attend the scheduled visit and take regular medication above 90% of prescribed doses (4). However, evidences show that, a considerable number of TB patients are interrupting their treatment due to various and interrelated psychological (10,11), socio- economic (11,12,16,17,21,43), behavioral (18–20), health care system (22) and health care workers related factors (13,14,23). In this study, the proportion of treatment non-adherence was found to be higher than studies recently reported from Ethiopia (14,27). Multivariable logistic regression analysis revealed that ART status, alcohol use, economic status, perceived barrier and psychological distress were able to independently predict TB treatment non-adherence. The overall non-adherence proportion of our study was nearly comparable with a previous study reported from Ethiopia (13). However, it was higher than other recently reported studies from the country (14,27). This difference on non-adherence level is most probably due to differences in adherence measurement techniques used and study population addressed. Study populations of both studies (14,27) were rural and urban mixed populations; however, our study population was urban dwellers. In addition, about 29.3% of the participants studied were immigrants from rural part of Addis Ababa before six months, and of these, 18.1% were daily laborers who were struggling to fulfill their daily living. These participants may easily enter into treatment interruption because of hard living situations and even they might have gone back to their original places abandoning the treatment to seek support from family as previous study reported (15). Moreover, a study conducted by Sendagire et al. (26) reported that urban movement and alcohol consumption had significant associations with loss to follow-up among urban population. Regarding non-adherence measurement technique, a study reported by Adane et al. (27) used pills counting technique and study reported by Kiros et al. (14) used VAS, but health care workers were used to estimate non-adherence level of patients. However, in our study, we used VAS and non-adherence level was estimated by individual patient themselves, being supported by health care workers. Hence, we assume that this non-adherence proportion differences occurred most probably due to these factors (non-adherence measurement techniques). Previous studies reported from Ethiopia (12,13) demonstrated that being on dual treatment (on TB and HIV treatment) and pills burden were the most significant barriers of TB treatment adherence. This result was consistent with our findings, i.e. TB patients on dual treatment (anti TB and ART) were 1.82 times more non-adherent than those who were not on dual treatment. Economic hardship is the highest determinant of treatment non-adherence. According to previous studies, TB patients who have financial limitation are more likely to be in devastating situation from lack of transportation cost and living costs which are important to regular treatment follow-up (12,16,17,21). Furthermore, poverty is one of the major barrier to healthy behavior practice like strictly following treatment, and it could easily put patients into risky behaviors such as tobacco smoking and alcohol misuse due to lack of enabling environment. Thus, being poor and practicing risky behaviors such as alcohol consumption and tobacco smoking would likely lead to poor health outcomes as the consequence of treatment non-adherence (21). Our study also revealed a similar result, and TB patients who were at high economic score were 31% times likely to be non-adherent than participants who were at low economic score. Naidoo et al. (21) and Sendagire et al. (26) reported that AUD risk was strongly associated with TB treatment non-adherence. The results of these studies were in agreement with our finding, and TB patients who were at AUD on WHO AUDIT 10- items were 1.89 times likely to be non-adherent than those who were not at AUD. This may be due to the fact that TB patients who drink alcohol may miss their medication to drink alcohol with friends and may miss their treatment due to memory and decision impairment related to alcohol. Moreover, according to a study reported from Uganda (23), as most TB patients who dirk alcohol are residing in slam areas and tend to give wrong addresses, they would be easily lost to follow-up and could not be traced back after interrupting their treatment. Perceived tangible (social, economic, health care system and health care worker factors) and individual belief about TB disease and its treatment barriers were associated with TB treatment non-adherence. This result was alongside with the study reported by Llongo (31), which showed the impact of a patient's incongruent belief on treatment adherence based on HBM. In addition, our finding was consistent with previous studies that showed the effect of tangible barriers on treatment adherence without applying HBM (18–21). According to a study reported by Prince et al. (44) and a systematic review reported by Pachi et al (10), the association between mental illness and other co-morbidities contributes to TB treatment non-adherence. These study findings were consistent with our finding in which TB patients who had psychological distress symptoms were 1.83 time more at risk of non-adherent than those who had no symptoms. The study questionnaire was administered by health care worker at the TB clinic of the selected study areas. Thus, health care workers could have overestimated the adherence level of patients to demonstrate their work performance. This could be the main limitation of this study. On the other hand, TB patients themselves may not give their own exact perception particularly related to health care workers and health care facilities, as the questionnaire was administered by health care works themselves. This may lead to under reporting of tangible barriers that are related to health care workers behaviors and health care facilities' services. Despite these limitations, we conclude that non-adherence level was 19.5% among TB patients on treatment. ART status, economic status, AUD, perceived barriers and psychological distress were significantly associated with TB treatment non-adherence. Thus, implementation of comprehensive interventions, focusing on poverty, AUD, perceived barriers to treatment and psychological counseling are important to enhance TB treatment adherence.
  34 in total

1.  Tuberculosis treatment default among HIV-TB co-infected patients in urban Uganda.

Authors:  Sawsan Elbireer; David Guwatudde; Peter Mudiope; Juliet Nabbuye-Sekandi; Yukari C Manabe
Journal:  Trop Med Int Health       Date:  2011-05-18       Impact factor: 2.622

2.  Common mental disorders in TB/HIV co-infected patients in Ethiopia.

Authors:  Amare Deribew; Markos Tesfaye; Yohannes Hailmichael; Ludwig Apers; Gemeda Abebe; Luc Duchateau; Robert Colebunders
Journal:  BMC Infect Dis       Date:  2010-07-09       Impact factor: 3.090

Review 3.  Treatment of active pulmonary tuberculosis in adults: current standards and recent advances. Insights from the Society of Infectious Diseases Pharmacists.

Authors:  Ronald G Hall; Richard D Leff; Tawanda Gumbo
Journal:  Pharmacotherapy       Date:  2009-12       Impact factor: 4.705

Review 4.  No health without mental health.

Authors:  Martin Prince; Vikram Patel; Shekhar Saxena; Mario Maj; Joanna Maselko; Michael R Phillips; Atif Rahman
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

5.  Adherence and non-adherence to treatments: focus on pharmacy practice in Nepal.

Authors:  Suresh Bastakoti; Saval Khanal; Bibek Dahal; Nirmala Tilija Pun
Journal:  J Clin Diagn Res       Date:  2013-04-01

6.  Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study.

Authors:  Pamela Naidoo; Karl Peltzer; Julia Louw; Gladys Matseke; Gugu McHunu; Bomkazi Tutshana
Journal:  BMC Public Health       Date:  2013-04-26       Impact factor: 3.295

Review 7.  Patient adherence to tuberculosis treatment: a systematic review of qualitative research.

Authors:  Salla A Munro; Simon A Lewin; Helen J Smith; Mark E Engel; Atle Fretheim; Jimmy Volmink
Journal:  PLoS Med       Date:  2007-07-24       Impact factor: 11.069

Review 8.  Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework.

Authors:  Rob Horne; Sarah C E Chapman; Rhian Parham; Nick Freemantle; Alastair Forbes; Vanessa Cooper
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

9.  Long distance travelling and financial burdens discourage tuberculosis DOTs treatment initiation and compliance in Ethiopia: a qualitative study.

Authors:  Takele Tadesse; Meaza Demissie; Yemane Berhane; Yigzaw Kebede; Markos Abebe
Journal:  BMC Public Health       Date:  2013-05-01       Impact factor: 3.295

10.  Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study.

Authors:  Mekdes K Gebremariam; Gunnar A Bjune; Jan C Frich
Journal:  BMC Public Health       Date:  2010-10-28       Impact factor: 3.295

View more
  11 in total

1.  The necessity of psychological interventions to improve compliance with Tuberculosis treatment and reduce psychological distress.

Authors:  Neeraj Agarwal; Parth Sarthi
Journal:  J Family Med Prim Care       Date:  2020-08-25

2.  Time Trend Analysis of Tuberculosis Treatment While Using Digital Adherence Technologies-An Individual Patient Data Meta-Analysis of Eleven Projects across Ten High Tuberculosis-Burden Countries.

Authors:  Liza M de Groot; Masja Straetemans; Noriah Maraba; Lauren Jennings; Maria Tarcela Gler; Danaida Marcelo; Mirchaye Mekoro; Pieter Steenkamp; Riccardo Gavioli; Anne Spaulding; Edwin Prophete; Margarette Bury; Sayera Banu; Sonia Sultana; Baraka Onjare; Egwuma Efo; Jason Alacapa; Jens Levy; Mona Lisa L Morales; Achilles Katamba; Aleksey Bogdanov; Kateryna Gamazina; Dzhumagulova Kumarkul; Orechova-Li Ekaterina; Adithya Cattamanchi; Amera Khan; Mirjam I Bakker
Journal:  Trop Med Infect Dis       Date:  2022-04-22

3.  Letter to the Editor.

Authors:  Basu Saurav
Journal:  Ethiop J Health Sci       Date:  2018-05

Review 4.  Comorbidities between tuberculosis and common mental disorders: a scoping review of epidemiological patterns and person-centred care interventions from low-to-middle income and BRICS countries.

Authors:  André Janse Van Rensburg; Audry Dube; Robyn Curran; Fentie Ambaw; Jamie Murdoch; Max Bachmann; Inge Petersen; Lara Fairall
Journal:  Infect Dis Poverty       Date:  2020-01-15       Impact factor: 4.520

5.  Protocol of a parallel group Randomized Control Trial (RCT) for Mobile-assisted Medication Adherence Support (Ma-MAS) intervention among Tuberculosis patients.

Authors:  Zekariyas Sahile; Lua Perimal-Lewis; Paul Arbon; Anthony John Maeder
Journal:  PLoS One       Date:  2021-12-31       Impact factor: 3.752

6.  Factors predicting self-report adherence (SRA) behaviours among DS-TB patients under the "Integrated model": a survey in Southwest China.

Authors:  Rui Zhang; Jie Pu; Jiani Zhou; Qingya Wang; Ting Zhang; Shili Liu; Geng Wang; Yong Chen; Jiaqing Liu; Daiyu Hu; Ying Li
Journal:  BMC Infect Dis       Date:  2022-03-01       Impact factor: 3.090

7.  Determinants of adherence to anti-TB treatment and associated factors among adult TB patients in Gondar city administration, Northwest, Ethiopia: based on health belief model perspective.

Authors:  Resom Berhe Gebremariam; Maereg Wolde; Aykerem Beyene
Journal:  J Health Popul Nutr       Date:  2021-11-27       Impact factor: 2.000

8.  Substance use disorders and adherence to antituberculosis medications in Southwest Ethiopia: a prospective cohort study.

Authors:  Matiwos Soboka; Markos Tesfaye; Kristina Adorjan; Wolfgang Krahl; Elias Tesfaye; Yimenu Yitayih; Ralf Strobl; Eva Grill
Journal:  BMJ Open       Date:  2021-07-05       Impact factor: 2.692

9.  Prevalence of psychological distress and associated factors among adult tuberculosis patients attending public health institutions in Dire Dawa and Harar cities, Eastern Ethiopia.

Authors:  Tegegn Mulatu Ayana; Kedir Teji Roba; Myrla Obejero Mabalhin
Journal:  BMC Public Health       Date:  2019-10-28       Impact factor: 3.295

10.  Prevalence and associated factors of psychological distress in tuberculosis patients in Northeast China: a cross-sectional study.

Authors:  Xu Chen; Ruiheng Wu; Jia Xu; Jiawei Wang; Mingcheng Gao; Yunting Chen; Yuanping Pan; Haoqiang Ji; Yuxin Duan; Meng Sun; Liang Du; Ling Zhou
Journal:  BMC Infect Dis       Date:  2021-06-12       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.